Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test

News   Jun 04, 2014

 
Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test
 
 
 
 

RELATED ARTICLES

Molecular Mechanism That Enable Neuronal Connections to Change With Development Discovered

News

Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.

READ MORE

Edith Heard Unanimously Selected as Next Director General of EMBL

News

At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.

READ MORE

CRISPR Transforms Living Cells Into Data Storage Devices

News

Genome engineering technology transforms living cells into archival data storage devices that capture, store, and propagate information over time.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE